DK268788A - (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater - Google Patents

(e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater

Info

Publication number
DK268788A
DK268788A DK268788A DK268788A DK268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A DK 268788 A DK268788 A DK 268788A
Authority
DK
Denmark
Prior art keywords
fluorphenyl
propenyl
piperazine
bis
phenyl
Prior art date
Application number
DK268788A
Other languages
English (en)
Other versions
DK268788D0 (da
Inventor
Jean Mesens
Achiel Paul Van Peer
Jozef Jan Pieter Heykants
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of DK268788D0 publication Critical patent/DK268788D0/da
Publication of DK268788A publication Critical patent/DK268788A/da

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nanotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fertilizers (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK268788A 1987-05-18 1988-05-17 (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater DK268788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5064487A 1987-05-18 1987-05-18

Publications (2)

Publication Number Publication Date
DK268788D0 DK268788D0 (da) 1988-05-17
DK268788A true DK268788A (da) 1988-11-19

Family

ID=21966482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK268788A DK268788A (da) 1987-05-18 1988-05-17 (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater

Country Status (19)

Country Link
EP (1) EP0292050B1 (da)
JP (1) JPS63303926A (da)
KR (1) KR880013559A (da)
AT (1) ATE69555T1 (da)
AU (1) AU603895B2 (da)
DE (1) DE3866281D1 (da)
DK (1) DK268788A (da)
ES (1) ES2051827T3 (da)
FI (1) FI882307A (da)
GR (1) GR3003482T3 (da)
HU (1) HU199073B (da)
IE (1) IE60937B1 (da)
IL (1) IL86395A (da)
NO (1) NO882134L (da)
NZ (1) NZ224497A (da)
PH (1) PH24425A (da)
PT (1) PT87496B (da)
RU (1) RU1829935C (da)
ZA (1) ZA883492B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU633959B2 (en) * 1989-08-17 1993-02-11 Cortecs Limited Pharmaceutical formulations
US5532002A (en) * 1989-08-17 1996-07-02 Cortecs Limited Gelatin pharmaceutical formulations
KR100371062B1 (ko) * 1992-11-27 2003-04-21 에프.에이치.포울딩 앤드 컴퍼니 리미티드 안정성이향상된주사가능한택솔조성물및이를제형화하는방법
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
FR2729307B1 (fr) * 1995-01-18 1997-04-18 Seppic Sa Utilisation d'esters d'acides gras ethoxyles comme composants auto-emulsionnables notamment utiles pour la preparation de produits de traitement phytosanitaires ou de medicaments a usage veterinaire ou humain
US6596706B1 (en) * 1997-11-07 2003-07-22 Daiichi Pharmaceutical Co., Ltd. Piperazine-cyclodextrin complexes
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
EP1448567B1 (en) * 2001-09-10 2009-12-30 Tibotec Pharmaceuticals Method for the preparation of hexahydro-furo 2,3-b furan-3-ol
AR038681A1 (es) * 2002-02-14 2005-01-26 Solvay Pharm Bv Formulacion oral de solucion solida de una sustancia activa pobremente soluble en agua
WO2004062692A1 (en) * 2003-01-13 2004-07-29 Solvay Pharmaceuticals B.V. Formulation of poorly water-soluble active substances
ES2661812T3 (es) 2009-10-16 2018-04-04 Mochida Pharmaceutical Co., Ltd. Composiciones
CN104069086A (zh) * 2014-07-22 2014-10-01 周有财 一种盐酸氟桂利嗪组合物胶囊及其制备方法
CN113262207B (zh) * 2020-02-17 2022-06-17 正大青春宝药业有限公司 一种盐酸氟桂利嗪胶囊制剂及其制备方法
CN115381791B (zh) * 2022-09-21 2023-06-16 迪沙药业集团有限公司 一种盐酸氟桂利嗪药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
EP0151987B1 (de) * 1984-01-28 1991-05-29 Roshdy Dr. Ismail Mittel zur Behandlung von Erkrankungen der Venen und des Analbereichs
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
US5047229A (en) * 1986-12-17 1991-09-10 Miles, Inc. Treatment of cardiovascular and cerebral toxicity using calcium modulators

Also Published As

Publication number Publication date
NZ224497A (en) 1990-04-26
ES2051827T3 (es) 1994-07-01
RU1829935C (ru) 1993-07-23
HU199073B (en) 1990-01-29
GR3003482T3 (en) 1993-02-17
AU603895B2 (en) 1990-11-29
IE881477L (en) 1988-11-18
NO882134L (no) 1988-11-21
IL86395A (en) 1992-11-15
PT87496A (pt) 1989-05-31
FI882307A0 (fi) 1988-05-17
AU1613288A (en) 1988-11-24
DE3866281D1 (de) 1992-01-02
NO882134D0 (no) 1988-05-16
IL86395A0 (en) 1988-11-15
FI882307A (fi) 1988-11-19
PT87496B (pt) 1992-09-30
JPS63303926A (ja) 1988-12-12
IE60937B1 (en) 1994-09-07
EP0292050A1 (en) 1988-11-23
EP0292050B1 (en) 1991-11-21
HUT46851A (en) 1988-12-28
ATE69555T1 (de) 1991-12-15
KR880013559A (ko) 1988-12-21
DK268788D0 (da) 1988-05-17
PH24425A (en) 1990-06-25
ZA883492B (en) 1990-01-31

Similar Documents

Publication Publication Date Title
DK268788D0 (da) (e)-1-(bis(4-fluorphenyl)methyl)-4-(3-phenyl-2-propenyl)piperazin-holdige praeparater
ATE60878T1 (de) Verfahren fuer die herstellung von stabilen oeligen zusammensetzungen.
DE69130830D1 (de) Insektizide, akarizide und fungizide aminopyrimidine
ATE143830T1 (de) Mikrokapseln mit wänden aus primären alkoholfunktionen enthaltenden polysacchariden, und zusammensetzungen daraus
ES2040727T3 (es) Un proceso para preparar una formulacion en aerosol en solucion de un analogo.
HUT49986A (en) Composition comprising alpha, omega-aminoalcohol derivative as active ingredient, for expelling insects and mites and process for producing new alpha, omega-aminoalcohol derivatives
KR850002377A (ko) 살충제 조성물
IT1243193B (it) Composizioni farmaceutiche orali a base di melatonina
DE68918923T2 (de) Stabile Emulsionsformulierungen von wasserunlöslichen organischen Pestiziden.
IL72306A0 (en) 5-aminomethyl-1,3-oxathiolanes,their preparation and their use in combatting pests
KR880008795A (ko) 피부 화장료
MY103337A (en) Stabilised pesticidal composition
DE69007956D1 (de) Antischwundadditiv enthaltender Dentalwirkstoff.
DK295789D0 (da) Stabil, vandig, primycinholdig suspoemulsion, dens fremstilling og anvendelse
DE3850044D1 (de) Azelastin-Embonat, Verfahren zu seiner Herstellung und pharmazeutische Zubereitungen, die als Wirkstoff Azelastin-Embonat enthalten.
FR2605223B1 (fr) Compositions therapeutiques stables a base d' huile vegetale hydrophobe et son procede de preparation
ATE46516T1 (de) Phosphonamidthioate-insektizide.
HUT49621A (en) Insecticides comprising thionophosphoric acid ester as active ingredient and process for producting the active ingredients
ES2058204T3 (es) Piridinas 3-substituidas y fungicidas que las contienen.
KR860006209A (ko) 제초제 조성물
KR890005081A (ko) 제초효과가 있는 신규 2-옥시아미노알킬리덴-시클로헥산-1,3-디온 유도체
ES2004454A6 (es) Procedimiento para la preparacion de preparados farmaceuticos con contenido de xilometazolina
FR2597480B1 (fr) Derives d'esters phosphoriques et compositions insecticides et acaricides contenant ces derives.
ECSP900691A (es) Compuestos heterociclicos (heterocyclic compounds)
KR870002764A (ko) 제초제 조성물

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment